Search clinical trials for: AZD 1981

Total 1407 results

AstraZeneca
Quintiles, Inc.

Completed

A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart

Rheumatoid Arthritis

United Kingdom
AstraZeneca

Completed

AZD0837 Extended Release (ER) Japan Study (ER J ph I)

Healthy

Japan
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

Alzheimer's Disease

Sweden
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Warfarin (DDI)

Alzheimer's Disease

Sweden
AstraZeneca

Completed

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.

Healthy

Japan
AstraZeneca

Completed

To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects

Healthy

Japan
AstraZeneca

Completed

Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

Healthy Volunteer

Japan
AstraZeneca

Completed

AZD5672 Bioavailability Study in Healthy Male and Female Subjects

Rheumatoid Arthritis

United Kingdom
AstraZeneca

Completed

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Healthy Volunteer

Netherlands
AstraZeneca

Completed

AZD8529 Multiple Ascending Dose Study in Healthy Subjects

Healthy Volunteer
AstraZeneca

Terminated

AZD1152 in Patients With Advanced Solid Malignancies-Study 1

Solid Tumors

Netherlands
AstraZeneca

Completed

Relative Bioavailability of Phase II and Phase III Formulations of AZD0530

Healthy

United Kingdom
AstraZeneca

Completed

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017

Healthy

Sweden
AstraZeneca

Completed

A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan

Advanced Solid Tumor

Japan
AstraZeneca

Completed

Exploratory Study to Assess the Pharmacokinetics of AZD5985

Healthy

Germany
AstraZeneca

Completed

AZD8566 Food Effect/Microtracer Study

Healthy Volunteer Study

United Kingdom
AstraZeneca

Completed

Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837

Healthy

Sweden
AstraZeneca

Completed

Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers

Healthy

United Kingdom
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Melanoma Neoplasms

United States, United Kingdom
AstraZeneca

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers (SAD)

Healthy

Sweden
AstraZeneca

Completed

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

Advanced Tumor

Netherlands
AstraZeneca

Terminated

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

Solid Tumours

United Kingdom
AstraZeneca

Completed

To Evaluate the Response to Glucagon During Hypoglycemia

Type 2 Diabetes

United States
AstraZeneca

Completed

To Evaluate 24-hr Glucose After OD vs BD AZD1656

Type II Diabetes

United States
AstraZeneca

Withdrawn

Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis (CYBER)

Cystic Fibrosis

Netherlands, Poland, Spain, Canada
AstraZeneca

Completed

Assess Safety, Tolerability and PK of AZD3199 in Japanese

Healthy

United Kingdom
AstraZeneca

Completed

Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors

Neoplasms

United States
AstraZeneca

Completed

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.

Pharmacokinetics

United Kingdom
AstraZeneca

Completed

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.

Healthy Volunteer

United Kingdom
AstraZeneca

Completed

Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation

Healthy

United States
AstraZeneca

Completed

Safety Study of AZD5672 in Renally Impaired Subjects

Renal Impairment

Germany
AstraZeneca

Completed

Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386

Pain

United Kingdom
AstraZeneca

Completed

AZD1981 Midazolam CYP4503A Induction Study

Healthy Male Volunteer

Sweden
AstraZeneca

Completed

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Type 2 Diabetes

United States
AstraZeneca

Completed

Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers

Rheumatoid Arthritis

United Kingdom
AstraZeneca

Completed

AZD8529 Single Ascending Dose Study (SAD)

Healthy Volunteer

United States
AstraZeneca

Completed

AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects (JSAD)

Healthy Volunteer

United States
AstraZeneca

Completed

Excretion of Radiolabelled AZD0837

Healthy

Sweden
AstraZeneca

Completed

Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066

Pain

United Kingdom
AstraZeneca

Completed

Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid (PET)

Alzheimer´s Disease

Sweden
AstraZeneca

Completed

Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors

Advanced Solid Metastatic Tumor

United Kingdom
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours

Neoplasm Metastasis

United Kingdom
AstraZeneca

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers

Healthy

Sweden
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Cytochrome P450 (Cocktail)

Alzheimer's Disease | Metabolism

Sweden
AstraZeneca

Completed

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia (HALO)

Schizophrenia

United States, Canada
AstraZeneca

Completed

Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers (SAD)

Healthy Volunteers

Sweden
AstraZeneca

Completed

Determine the Effect of Multiple Doses of AZD7325, CYP Study (CYP)

Healthy Volunteer
AstraZeneca

Completed

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

Healthy

Sweden
AstraZeneca

Completed

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

Healthy Volunteers

United Kingdom
AstraZeneca

Completed

Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days (TQT)

Healthy

3

Subscribe